Skip to main content
SpringerLink
Log in

Biological Treatment in Cartilage Injuries

  • Chapter
  • First Online:
The Sports Medicine Physician

  • 2327 Accesses

Abstract

In occidental societies, a great number of people practice sport regularly at all ages. In this context, cartilage injury incidences have become higher and higher. They are frequently diagnosed during knee arthroscopy even in asymptomatic patients. However, patients commonly present with pain, recurrent effusion, and loss of function. Concomitantly with the increasing incidence, the expectations of patients about function restore have risen as well. Since articular cartilage is characterized by a poor intrinsic regenerative capacity, treatment of these lesions is particularly challenging.

Orthopedic surgeons should face this pathology not only because it is symptomatic but also for the risk of more extensive joint damage and further degeneration of the whole articular compartment.

Several therapeutic strategies have been developed, both conservative and surgical. In this chapter we will focus on infiltrative therapies, such as platelet-rich plasma (PRP), mesenchymal stem cells (MSCs), and bioengineered osteochondral scaffolds.

Platelet-rich plasma (PRP) is a concentrate obtained from autologous blood containing high concentrations of human platelets and platelet-derived growth factors. They are capable of modulating the early healing response and influencing inflammation, angiogenesis, and cell migration. PRP is a safe procedure, and clinical outcome is encouraging, even if it is difficult to establish PRP efficacy because authors have used different PRP formulations, with a large inter-product variability.

Another powerful tool for cartilage repair emerging in recent years is mesenchymal stem cells (MSC). Their regenerative effects are due to their immunomodulatory and anti-inflammatory action but above all to their structural contribution to tissue repair. They have a capacity for self-renewal, stemness maintenance, and the marked ability to differentiate into a variety of connective tissues. MSCs can be isolated from human sources other than the bone marrow, such as adipose tissue. Studies available suggest a potential for these cell-based treatments to be developed and to represent a promising new approach with preliminary interesting findings. Nevertheless, many aspects remain to be clarified and optimized.

The awareness of the involvement of the subchondral bone in many of these lesions resulted in the need to develop cell-free treatment strategies focused on the entire osteochondral unit. Therefore, surgical techniques move on from autologous chondrocyte implantation (ACI) and autograft or allograft osteochondral implantation to new bioengineered scaffolds.

Ideally, a scaffold should have the following characteristics:

  • Three-dimensional and highly porous with an interconnected pore network for cell growth and flow transport of nutrients and metabolic waste.

  • Biocompatible and bioresorbable with a controllable degradation and resorption rate to match cell/tissue growth in vitro and/or in vivo.

  • Suitable surface chemistry for cell attachment, proliferation, and differentiation and mechanical properties to match those of the tissues at the site of implantation.

Among them MaioRegen® and, more recently, Agili-C® have shown some of the most promising results.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Marcacci M, Filardo G, Kon E. Treatment of cartilage lesions: what works and why? Injury. 2013;44(Suppl 1):S11–5.

    Article  PubMed  Google Scholar 

  2. Widuchowski W, Widuchowski J, Trzaska T. Articular cartilage defects: study of 25,124 knee arthroscopies. Knee. 2007;14(3):177–82.

    Article  CAS  PubMed  Google Scholar 

  3. Arøen A, Løken S, Heir S, et al. Articular cartilage lesions in 993 consecutive knee arthroscopies. Am J Sports Med. 2004;32(1):211–5.

    Article  PubMed  Google Scholar 

  4. Hjelle K, Solheim E, Strand T, et al. Articular cartilage defects in 1,000 knee arthroscopies. Arthroscopy. 2002;18(7):730–4.

    Article  PubMed  Google Scholar 

  5. Noyes FR, Bassett RW, Grood ES, Butler DL. Arthroscopy in acute traumatic hemarthrosis of the knee: incidence of anterior cruciate tears and other injuries. J Bone Joint Surg Am. 1980;62:687–95.

    Article  CAS  PubMed  Google Scholar 

  6. Buckwalter JA, Mankin HJ. Articular cartilage: tissue design and chondrocyte–matrix interactions. Instr Course Lect. 1998;47:477–86.

    CAS  PubMed  Google Scholar 

  7. Buckwalter JA. Articular cartilage: injuries and potential for healing. J Orthop Sports Phys Ther. 1998;28(4):192–202.

    Article  CAS  PubMed  Google Scholar 

  8. Gratz KR, Wong BL, Bae WC, Sah RL. The effects of focal articular defects on intra-tissue strains in the surrounding and opposing cartilage. Biorheology. 2008;45(3–4):193–207.

    PubMed  Google Scholar 

  9. Schinhan M, Gruber M, Vavken P, et al. Critical-size defect induces unicompartmental osteoarthritis in a stable ovine knee. J Orthop Res. 2012;30(2):214–20.

    Article  PubMed  Google Scholar 

  10. Andia I, Abate M. Platelet-rich plasma: underlying biology and clinical correlates. Regen Med. 2013;8:645–58.

    Article  CAS  PubMed  Google Scholar 

  11. Andia I, Sanchez M, Maffulli N. Tendon healing and platelet-rich plasma therapies. Expert Opin Biol Ther. 2010;10:1415–26.

    Article  PubMed  Google Scholar 

  12. Bosch G, Moleman M, Barneveld A, van Weeren PR, van Schie HT. The effect of platelet-rich plasma on the neovascularization of surgically created equine superficial digital flexor tendon lesions. Scand J Med Sci Sports. 2011;21:554–61.

    Article  CAS  PubMed  Google Scholar 

  13. Lyras D, Kazakos K, Verettas D, Polychronidis A, Simopoulos C, Botaitis S, Agrogiannis G, Kokka A, Patsouris E. Immunohistochemical study of angiogenesis after local administration of platelet-rich plasma in a patellar tendon defect. Int Orthop. 2010;34:143–8.

    Article  PubMed  Google Scholar 

  14. Lyras DN, Kazakos K, Verettas D, Polychronidis A, Tryfonidis M, Botaitis S, Agrogiannis G, Simopoulos C, Kokka A, Patsouris E. The influence of platelet-rich plasma on angiogenesis during the early phase of tendon healing. Foot Ankle Int. 2009;30:1101–6.

    Article  PubMed  Google Scholar 

  15. Alvarez P, Green PG, Levine JD. Role for monocyte chemoattractant protein-1 in the induction of chronic muscle pain in the rat. Pain. 2014;155:1161–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Andia I, Rubio-Azpeitia E, Maffulli N. Platelet-rich plasma modulates the secretion of inflammatory/angiogenic proteins by inflamed tenocytes. Clin Orthop Relat Res. 2015;473(5):1624–34.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Mann KG. Biochemistry and physiology of blood coagulation. Thromb Haemost. 1999;82:165–74.

    Article  CAS  PubMed  Google Scholar 

  18. Xie X, Wang Y, Zhao C, Guo S, Liu S, Jia W, Tuan RS, Zhang C. Comparative evaluation of MSCs from bone marrow and adipose tissue seeded in PRP-derived scaffold for cartilage regeneration. Biomaterials. 2012;33:7008–18.

    Article  CAS  PubMed  Google Scholar 

  19. Akeda K, An HS, Okuma M, Attawia M, Miyamoto K, Thonar EJ, Lenz ME, Sah RL, Masuda K. Platelet-rich plasma stimulates porcine articular chondrocyte proliferation and matrix biosynthesis. Osteoarthr Cartil. 2006;14:1272–80.

    Article  CAS  Google Scholar 

  20. Chien CS, Ho HO, Liang YC, Ko PH, Sheu MT, Chen CH. Incorporation of exudates of human platelet-rich fibrin gel in biodegradable fibrin scaffolds for tissue engineering of cartilage. J Biomed Mater Res B Appl Biomater. 2012;100:948–55.

    Article  PubMed  Google Scholar 

  21. Spreafico A, Chellini F, Frediani B, Bernardini G, Niccolini S, Serchi T, Collodel G, Paffetti A, Fossombroni V, Galeazzi M, Marcolongo R, Santucci A. Biochemical investigation of the effects of human platelet releasates on human articular chondrocytes. J Cell Biochem. 2009;108:1153–65.

    Article  CAS  PubMed  Google Scholar 

  22. Kaps C, Loch A, Haisch A, Smolian H, Burmester GR, Haupl T, Sittinger M. Human platelet supernatant promotes proliferation but not differentiation of articular chondrocytes. Med Biol Eng Comput. 2002;40:485–90.

    Article  CAS  PubMed  Google Scholar 

  23. Gaissmaier C, Fritz J, Krackhardt T, Flesch I, Aicher WK, Ashammakhi N. Effect of human platelet supernatant on proliferation and matrix synthesis of human articular chondrocytes in monolayer and three-dimensional alginate cultures. Biomaterials. 2005;26:1953–60.

    Article  CAS  PubMed  Google Scholar 

  24. Drengk A, Zapf A, Sturmer EK, Sturmer KM, Frosch KH. Influence of platelet-rich plasma on chondrogenic differentiation and proliferation of chondrocytes and mesenchymal stem cells. Cells Tissues Organs. 2009;189:317–26.

    Article  PubMed  Google Scholar 

  25. Kon E, Filardo G, Di Matteo B, Marcacci M. PRP for the treatment of cartilage pathology. Open Orthop J. 2013;7:120–8.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Marx R. Platelet rich plasma (PRP): what is PRP and what is not PRP? Implant Dent. 2001;10:225–8.

    Article  CAS  PubMed  Google Scholar 

  27. Dohan Ehrenfest DM, Rasmuson L, Albrektsson T. Classification of platelet concentrates: from pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (LPRF). Trends Biotechnol. 2009;27(3):158–67.

    Article  CAS  PubMed  Google Scholar 

  28. Tschon M, Fini M, Giardino R, et al. Lights and shadows concerning platelet products for musculoskeletal regeneration. Front Biosci. 2011;3:96–107.

    Google Scholar 

  29. Torricelli P, Fini M, Filardo G, et al. Regenerative medicine for the treatment of musculoskeletal overuse injuries in competition horses. Int Orthop. 2011;35(10):1569–76.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Boswell SG, Cole BJ, Sundman EA, Karas V, Fortier LA. Platelet-rich plasma: a milieu of bioactive factors. Arthroscopy. 2012;28(3):429–39.

    Article  PubMed  Google Scholar 

  31. Wasterlain A, Braun HJ, Dragoo JL. Contents and formulations of platelet-rich plasma. Oper Tech Orthop. 2012;22(1):33–42.

    Article  Google Scholar 

  32. Arnoczky S, Delos D, Rodeo S. What is platelet-rich plasma? Oper Tech Sports Med. 2011;19(3):142–8.

    Article  Google Scholar 

  33. Giannini S, Buda R, Vannini F, Cavallo M, Grigolo B. One-step bone marrow-derived cell transplantation in talar osteochondral lesions. Clin Orthop Relat Res. 2009;467(12):3307–20.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Giannini S, Buda R, Cavallo M, et al. Cartilage repair evolution in post-traumatic osteochondral lesions of the talus: from open field autologous chondrocyte to bone-marrow-derived cells transplantation. Injury. 2010;41(11):1196–203.

    Article  PubMed  Google Scholar 

  35. Buda R, Vannini F, Cavallo M, Grigolo B, Cenacchi A, Giannini S. Osteochondral lesions of the knee: a new one-step repair technique with bone-marrow-derived cells. J Bone Joint Surg Am. 2010;92(Suppl 2):2–11.

    Article  PubMed  Google Scholar 

  36. Dhollander AA, De Neve F, Almqvist KF, et al. Autologous matrix-induced chondrogenesis combined with platelet-rich plasma gel technical description and a five pilot patients report. Knee Surg Sports Traumatol Arthrosc. 2011;19(4):536–42.

    Article  CAS  PubMed  Google Scholar 

  37. Siclari A, Mascaro G, Gentili C, Cancedda R, Boux E. A cell-free scaffold-based cartilage repair provides improved function hyaline-like repair at one year. Clin Orthop Relat Res. 2012;470(3):910–9.

    Article  PubMed  Google Scholar 

  38. Mei-Dan O, Carmont MR, Laver L, Mann G, Maffulli N, Nyska M. Platelet-rich plasma or hyaluronate in the management of osteochondral lesions of the talus. Am J Sports Med. 2012;40(3):534–41.

    Article  PubMed  Google Scholar 

  39. Filardo G, Kon E, Pereira Ruiz MT, et al. Platelet-rich plasma intra-articular injections for cartilage degeneration and osteoarthritis: single- versus double-spinning approach. Knee Surg Sports Traumatol Arthrosc. 2012;20(10):2082–91.

    Article  PubMed  Google Scholar 

  40. Spaková T, Rosocha J, Lacko M, Harvanová D, Gharaibeh A. Treatment of knee joint osteoarthritis with autologous platelet-rich plasma in comparison with hyaluronic acid. Am J Phys Med Rehabil. 2012;91(5):411–7.

    Article  PubMed  Google Scholar 

  41. Sánchez M, Fiz N, Azofra J, et al. A randomized clinical trial evaluating plasma rich in growth factors (PRGF-Endoret) versus hyaluronic acid in the short-term treatment of symptomatic knee osteoarthritis. Arthroscopy. 2012;28(8):1070–8.

    Article  PubMed  Google Scholar 

  42. Filardo G, Madry H, Jelic M, Roffi A, Cucchiarini M, Kon E. Mesenchymal stem cells for the treatment of cartilage lesions: from preclinical findings to clinical application in orthopaedics. Knee Surg Sports Traumatol Arthrosc. 2013;21(8):1717–29.

    Article  PubMed  Google Scholar 

  43. Caplan AI. Mesenchymal stem cells: cell-based reconstructive therapy in orthopedics. Tissue Eng. 2005;11(7–8):1198–211.

    Article  CAS  PubMed  Google Scholar 

  44. Singer NG, Caplan AI. Mesenchymal stem cells: mechanisms of inflammation. Annu Rev Pathol. 2011;6:457–78.

    Article  CAS  PubMed  Google Scholar 

  45. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Dj P, Horwitz E. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8(4):315–7.

    Article  CAS  PubMed  Google Scholar 

  46. Friedenstein AJ, Piatetzky-Shapiro II, Petrakova KV. Osteogenesis in transplants of bone marrow cells. J Embryol Exp Morphol. 1966;6(3):381–90.

    Google Scholar 

  47. Caplan AI, Koutroupas S. The control of muscle and cartilage development in the chick limb: the role of differential vascularization. J Embryol Exp Morphol. 1973;29(3):571–83.

    CAS  PubMed  Google Scholar 

  48. Spencer ND, Gimble JM, Lopez MJ. Mesenchymal stromal cells: past, present, and future. Vet Surg. 2011;40(2):129–39.

    Article  PubMed  Google Scholar 

  49. Wakitani S, Goto T, Pineda SJ, Young RG, Mansour JM, Caplan AI, Goldberg VM. Mesenchymal cell-based repair of large, full-thickness defects of articular cartilage. J Bone Joint Surg Am. 1994;76(4):579–92.

    Article  CAS  PubMed  Google Scholar 

  50. Quarto R, Mastrogiacomo M, Cancedda R, Kutepov SM, Mukhachev V, Lavroukov A, Kon E, Marcacci M. Repair of large bone defects with the use of autologous bone marrow stromal cells. N Engl J Med. 2011;344(5):385–6.

    Article  Google Scholar 

  51. Lodi D, Iannitti T, Palmieri B. Stem cells in clinical practice: applications and warnings. J Exp Clin Cancer Res. 2011;30:9.

    Article  PubMed  PubMed Central  Google Scholar 

  52. Davatchi F, Abdollahi BS, Mohyeddin M, Shahram F, Nikbin B. Mesenchymal stem cell therapy for knee osteoarthritis. Preliminary report of four patients. Int J Rheum Dis. 2011;14(2):211–5.

    Article  PubMed  Google Scholar 

  53. Chang CH, Kuo TF, Lin FH, Wang JH, Hsu YM, Huang HT, Loo ST, Fang HW, Liu HC, Wang WC. Tissue engineering based cartilage repair with mesenchymal stem cells in a porcine model. J Orthop Res. 2011;29(12):1874–80.

    Article  CAS  PubMed  Google Scholar 

  54. Saw KY, Anz A, Merican S, Tay YG, Ragavanaidu K, Jee CSY, McGuire DA. Articular cartilage regeneration with autologous peripheral blood progenitor cells and hyaluronic acid after arthroscopic subchondral drilling: a report of 5 cases with histology. Arthroscopy. 2011;27(4):493–506.

    Article  PubMed  Google Scholar 

  55. Breitbach M, Bostani T, Roell W, Xia Y, Dewald O, Nygren JM, Fries JW, Tiemann K, Bohlen H, Hescheler J, Welz A, Bloch W, Jacobsen SE, Fleischmann BK. Potential risks of bone marrow cell transplantation into infarcted hearts. Blood. 2007;110(4):1362–9.

    Article  CAS  PubMed  Google Scholar 

  56. Wakitani S, Okabe T, Horibe S, Mitsuoka T, Saito M, Koyama T, Nawata M, Tensho K, Kato H, Uematsu K, Kuroda R, Kurosaka M, Yoshiya S, Hattori K, Ohgushi H. Safety of autologous bone marrow-derived mesenchymal stem cell transplantation for cartilage repair in 41 patients with 45 joints followed for up to 11 years and 5 months. J Tissue Eng Regen Med. 2011;5(2):146–50.

    Article  PubMed  Google Scholar 

  57. Keeney M, Pandit A. The osteochondral junction and its repair via bi-phasic tissue engineering scaffolds. Tissue Eng Part B Rev. 2009;15(1):55–73.

    Article  CAS  PubMed  Google Scholar 

  58. Kocher MS, Tucker R, Ganley TJ, Flynn JM. Management of osteochondritis dissecans of the knee: current concepts review. Am J Sports Med. 2006;34(7):1181–91.

    Article  PubMed  Google Scholar 

  59. Pape D, Filardo G, Kon E, Van Dijk CN, Madry H. Disease-specific clinical problems associated with the subchondral bone. Knee Surg Sports Traumatol Arthrosc. 2010;18(4):448–62.

    Article  PubMed  Google Scholar 

  60. Gomoll AH, Madry H. The subchondral bone in articular cartilage repair : current problems in the surgical management. Knee Surg Sports Traumatol Arthrosc. 2010;18(4):434–47.

    Article  PubMed  PubMed Central  Google Scholar 

  61. Gratz KR, Wong BL, Bae WC, Sah RL. The effects of focal articular defects on cartilage contact mechanics. J Orthop Res. 2009;27(5):584–92.

    Article  PubMed  PubMed Central  Google Scholar 

  62. Wong BL, Kim SHC, Antonacci JM, Mcilwraith CW, Sah RL. Cartilage shear dynamics during tibio-femoral articulation: effect of acute joint injury and tribosupplementation on synovial fluid lubrication. Osteoarthr Cartil. 2010;18(3):464–71.

    Article  CAS  Google Scholar 

  63. Von Der Mark K, Gauss V, Von Der Marl H, Muller P. Relationship between cell shape and type of collagen synthesised as chondrocytes lose their cartilage phenotype in culture. Nature. 1977;267(5611):531–2.

    Article  PubMed  Google Scholar 

  64. Freed L, Marquis J, Nohria A. Neocartilage formation in vitro and in vivo using cells cultured on synthetic biodegradable polymers. J Biomed Mater Res. 1993;27(1):11–23.

    Article  CAS  PubMed  Google Scholar 

  65. Gricolo B, Lisignoli G, Piacentini A, Fiorini M, Gobbi P, Mazzotti G, Duca M, Pavesio A, Facchini A. Evidence for redifferentiation of human chondrocytes grown on a hyaluronan-based biomaterial (HYAFF11): melocular, immunohistochemical and ultrastructural analysis. Biomaterials. 2002;23(4):1187–95.

    Article  Google Scholar 

  66. Caterson EJ, Nesti LJ, Li WJ, Danielson KG, Albert TJ, Vaccaro AR, Tuan RS. Three-dimensional cartilage formation by bone marrow-derived cells seed in polyactide/alginate amalgam. J Biomed Mater Res. 2001;57(3):394–403.

    Article  CAS  PubMed  Google Scholar 

  67. Marcacci M, Kon E, Zaffagnini S, Filardo G, Delcogliano M, Neri MP, Iacono F, Hollander AP. Arthroscopic second generation autologous chondrocyte implantation. Knee Surg Sports Traumatol Arthrosc. 2007;15(5):610–9.

    Article  PubMed  Google Scholar 

  68. Filardo G, Kon E, Di Martino A, Iacono F, Marcacci M. Arthroscopic second-generation autologous chondrocyte implantation: a prospective 7-year follow-up study. Am J Sports Med. 2011;39(10):2153–60.

    Article  PubMed  Google Scholar 

  69. Podskubka A, Povysil C, Kubes R, Sprindrich J, Sedlacek R. Treatment of deep cartilage defects of the knee with autologous chondrocyte transplantation on a hyaluronic acid ester scaffolds (Hyalograft C). Acta Chir Orthop Traumatol Cech. 2006;73(4):251–63.

    CAS  PubMed  Google Scholar 

  70. Hollander AP, Dickinson SC, Sims TJ, Brun P, Cortivo R, Kon E, Marcacci M, Zanasi S, Borrione A, De Luca C, Pavesio A, Soranzo C, Abatangelo G. Maturation of tissue engineered cartilage implanted in injured and osteoarthritic human knees. Tissue Eng. 2006;12(7):1787–98.

    Article  CAS  PubMed  Google Scholar 

  71. Kon E, Di Martino A, Filardo G, Tetta C, Busacca M, Iacono F, Delcogliano M, Albisinni U, Marcacci M. Second-generation autologous chondrocyte transplantation: MRI findings and clinical correlations at a minimum 5-year follow-up. Eur J Radiol. 2011;79(3):382–8.

    Article  CAS  PubMed  Google Scholar 

  72. Lu Y, Dhanaraj S, Wang Z, et al. Minced cartilage without cell culture serves as an effective cell source for cartilage repair. J Orthop Res. 2006;24(6):1261–70.

    Article  PubMed  Google Scholar 

  73. Kon E, Robinson D, Verdonk P, Drobnic M, Patrascu J, Dulic O. A novel aragonite-based scaffold for osteochondral regeneration: early experience on human implants and technical developments. Injury. 2016;47(Suppl 6):S27–32.

    Article  PubMed  Google Scholar 

  74. Wang X, Grogan SP, Rieser F, Winkelmann V, Maquet V, La Berge M. Tissue engineering of biphasic cartilage constructs using various biodegradable scaffolds: an in vitro study. Biomaterials. 2004;25(17):3681–8.

    Article  CAS  PubMed  Google Scholar 

  75. Woodfield TB, Malda J, De Wijn J, Peters F, Riesle J, Van Blitterswijk CA. Design of porous scaffolds for cartilage tissue engineering using a three-dimensional fiber-deposition technique. Biomaterials. 2004;25(18):4149–61.

    Article  CAS  PubMed  Google Scholar 

  76. Kon E, Delcogliano M, Filardo G, et al. A novel nano-composite multi-layered biomaterial for treatment of osteochondral lesions: technique note and an early stability pilot clinical trial. Injury. 2010;41(7):693–701.

    Article  CAS  PubMed  Google Scholar 

  77. Kon E, Delcogliano M, Filardo G, et al. Orderly osteochondral regeneration in a sheep model using a novel nano-composite multilayered biomaterial. J Orthop Res. 2010;28(1):116–24.

    PubMed  Google Scholar 

  78. Kon E, Delcogliano M, Filardo G, Busacca M, Di Martino A, Marcacci M. Novel nano-composite multilayered biomaterial for osteochondral regeneration a pilot clinical trial. Am J Sports Med. 2011;39(6):1180–90.

    Article  PubMed  Google Scholar 

  79. Demers C, Hamdy C, Corsi K, Chellat F, Tabrizian M, Yahia L. Natural coral exoskeleton as a bone graft substitute: a review. Biomed Mater Eng. 2002;12(1):15–35.

    PubMed  Google Scholar 

  80. Kon E, Filardo G, Shani J, Altschuler N, Levy A, Zaslav K, Eisman JE, Robinson D. Osteochondral regeneration with a novel aragonite-hyaluronate biphasic scaffold: up to 12-month follow-up study in a goat model. J Orthop Surg Res. 2015;10:81.

    Article  PubMed  PubMed Central  Google Scholar 

  81. Kon E, Robinson D, Verdonk P, Drobnic M, Patrascu JM, Dulic O, Gavrilovic G, Filardo G. A novel aragonite-based scaffold for osteochondral regeneration: early experience on human implants and technical developments. Injury. 2016;47(Suppl 6):S27–32.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Biomedical Sciences, Humanitas University, Milan, Italy

    Elizaveta Kon, Berardo Di Matteo, Francesco Iacono, Filippo Vandenbulcke, Nicolò Danilo Vitale & Maurilio Marcacci

  2. Humanitas Clinical and Research Center, Milan, Italy

    Elizaveta Kon, Berardo Di Matteo, Francesco Iacono, Filippo Vandenbulcke, Nicolò Danilo Vitale & Maurilio Marcacci

Authors
  1. Elizaveta Kon
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Berardo Di Matteo
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Francesco Iacono
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Filippo Vandenbulcke
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Nicolò Danilo Vitale
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Maurilio Marcacci
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Orthopedics and Traumatology, State University of Campinas – UNICAMP, Campinas / Sao Paulo, Brazil

    Sérgio Rocha Piedade

  2. Orthopaedic Sports Medicine, University of Munich (TUM), München, Bayern, Germany

    Andreas B. Imhoff

  3. Ascot Hospital, Auckland, New Zealand

    Mark Clatworthy

  4. Department of Orthopedics & Traumatology, Federal University of São Paulo, Vila Clementino - São Paulo, São Paulo, Brazil

    Moises Cohen

  5. Espregueira-Mendes Sports Centre, Clínica do Dragão, Porto, Portugal

    João Espregueira-Mendes

Rights and permissions

Reprints and permissions

Copyright information

© 2019 ISAKOS

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Kon, E., Di Matteo, B., Iacono, F., Vandenbulcke, F., Vitale, N.D., Marcacci, M. (2019). Biological Treatment in Cartilage Injuries. In: Rocha Piedade, S., Imhoff, A., Clatworthy, M., Cohen, M., Espregueira-Mendes, J. (eds) The Sports Medicine Physician. Springer, Cham. https://doi.org/10.1007/978-3-030-10433-7_44

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-10433-7_44

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-10432-0

  • Online ISBN: 978-3-030-10433-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation